Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Journal of Comparative Effectiveness Research
|
November 19, 2013
Interview: access to richer data promises to usher in a new era of insight into patient heterogeneity
Marc L Berger
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 5, 2013
Can the pharmaceutical industry embrace comparative effectiveness research? A view from inside
Marc L Berger
Journal of Comparative Effectiveness Research
|
October 21, 2017
The joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making: an interview with Marc Berger
Marc L Berger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 19, 2003
Rational formulary decision making: is drug classification rational?
Marc L Berger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2012
The view of a model user on the ISPOR-SMDM modeling good research task force report
Marc L Berger
Pharmacoeconomics
|
September 14, 2010
Comparative effectiveness research: the view from a pharmaceutical company
Marc L Berger, David Grainger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 31, 2022
How Can We Make More Rapid Progress in the Leveraging of Real-World Evidence by Regulatory Decision Makers?
Marc L Berger, William Crown
Health Services & Outcomes Research Methodology
|
September 6, 2016
Big Data: transforming drug development and health policy decision making
Demissie Alemayehu, Marc L Berger
Journal of Comparative Effectiveness Research
|
March 21, 2014
Big data, advanced analytics and the future of comparative effectiveness research
Marc L Berger, Vitalii Doban
Medical Care
|
August 2, 2005
Cost-effectiveness analysis: from science to application
Marc L Berger, Steven Teutsch
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Journal of Comparative Effectiveness Research
|
November 19, 2013
Interview: access to richer data promises to usher in a new era of insight into patient heterogeneity
Marc L Berger
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 5, 2013
Can the pharmaceutical industry embrace comparative effectiveness research? A view from inside
Marc L Berger
Journal of Comparative Effectiveness Research
|
October 21, 2017
The joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making: an interview with Marc Berger
Marc L Berger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 19, 2003
Rational formulary decision making: is drug classification rational?
Marc L Berger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2012
The view of a model user on the ISPOR-SMDM modeling good research task force report
Marc L Berger
Pharmacoeconomics
|
September 14, 2010
Comparative effectiveness research: the view from a pharmaceutical company
Marc L Berger, David Grainger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 31, 2022
How Can We Make More Rapid Progress in the Leveraging of Real-World Evidence by Regulatory Decision Makers?
Marc L Berger, William Crown
Health Services & Outcomes Research Methodology
|
September 6, 2016
Big Data: transforming drug development and health policy decision making
Demissie Alemayehu, Marc L Berger
Journal of Comparative Effectiveness Research
|
March 21, 2014
Big data, advanced analytics and the future of comparative effectiveness research
Marc L Berger, Vitalii Doban
Medical Care
|
August 2, 2005
Cost-effectiveness analysis: from science to application
Marc L Berger, Steven Teutsch
Page
of 6